XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2017
Apr. 30, 2017
Current Assets:    
Cash and cash equivalents $ 11,792 $ 12,506
Restricted cash 1,392 1,435
Receivables, less allowance; $227; $191, on each respective date 33,245 29,889
Inventories 16,439 14,935
Prepaid expenses and other current assets 1,888 1,047
Total Current Assets 64,756 59,812
Property, plant and equipment, at cost 52,999 51,568
Accumulated depreciation (38,938) (37,541)
Net Property, Plant and Equipment 14,061 14,027
Deferred income taxes 3,108 3,158
Other 3,943 3,919
Total Other Assets 7,051 7,077
Total Assets 85,868 80,916
Current Liabilities:    
Short-term borrowings and interest rate swaps 7,711 3,591
Current portion of long-term debt 1,167 918
Accounts payable 14,364 11,995
Employee compensation and amounts withheld 2,808 2,765
Deferred revenue 1,506 5,806
Other accrued expenses 2,954 1,852
Total Current Liabilities 30,510 26,927
Long-term debt 1,848 2,431
Accrued pension and deferred compensation costs 8,192 8,301
Total Liabilities 40,550 37,659
Commitments and Contingencies
Stockholders' Equity:    
Common Stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,724 shares; 2,715 shares; - Outstanding - 2,721 shares; 2,712 shares, on each respective date 6,809 6,789
Additional paid-in-capital 2,861 2,695
Retained earnings 41,775 39,771
Accumulated other comprehensive loss (6,455) (6,319)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 44,937 42,883
Noncontrolling interest 381 374
Total Equity 45,318 43,257
Total Liabilities and Equity $ 85,868 $ 80,916